Ibuprofen Suspension
NDC Package 50090-8175-0

11-digit billing NDC: 50090817500
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ibuprofen suspension is carefully consider the potential benefits and risks of ibuprofen oral suspension and other treatment options before deciding to use ibuprofen. This formulation utilizes a suspension delivery system. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-8175 and is authorized under FDA application ANDA209204.

Identification & Billing

NDC Package Code
50090-8175-0
Package Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Product Code
50090-8175
11-Digit Billing Format
50090817500

Clinical Specifications

Proprietary Name
Ibuprofen
Non-Proprietary Name
Ibuprofen
Substance Name
Ibuprofen
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
IBUPROFEN 100 mg/5mL
Pharmacologic Class
Usage Information
Carefully consider the potential benefits and risks of ibuprofen oral suspension and other treatment options before deciding to use ibuprofen. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). In Pediatric Patients, Ibuprofen Oral Suspension is indicated:For reduction of fever in patients aged 6 months up to 2 years of age.For relief of mild to moderate pain in patients aged 6 months up to 2 years of age.For relief of signs and symptoms of juvenile arthritis.In Adults, Ibuprofen Oral Suspension is indicated:For treatment of primary dysmenorrhea.For relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.Since there have been no controlled trials to demonstrate whether there is any beneficial effect or harmful interaction with the use of ibuprofen in conjunction with aspirin, the combination cannot be recommended (see PRECAUTIONS-Drug Interactions).

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
Product Type
Human Prescription Drug
FDA Application #
ANDA209204
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-23-2017
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-8175-0 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Ibuprofen, a human prescription drug labeled by A-s Medication Solutions. This suspension is formulated for oral use and contains ibuprofen as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by A-s Medication Solutions on June 23, 2017. The current certification is valid through December 31, 2027.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090817500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-8175-0
11-Digit CMS (5-4-2)
50090-8175-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.